Who Should Decide? Decision-Making Preferences for Primary HPV Testing for Cervical Cancer Screening Among U.S. Women
Revised U.S. guidelines for cervical cancer screening provide the option of primary human papillomavirus (HPV) testing, Pap testing, or co-testing. Primary HPV testing has not yet been an option for American women, and women may be reluctant to change screening methods. The purpose of this study was...
Guardado en:
Autores principales: | Erika L. Thompson, Ashvita Garg, Katharine J. Head, Stacey B. Griner, Annalynn M. Galvin, Tracey E. Barnett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
New Prairie Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8690bda4e9054445b5b98cc328708179 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Federica Inturrisi, et al.
Publicado: (2021) -
Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
por: Masayuki Sekine, et al.
Publicado: (2021) -
Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand
por: Naomi Brewer, et al.
Publicado: (2021) -
A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
por: Rei Haruyama, et al.
Publicado: (2021) -
A New HPV score System Predicts the Survival of Patients With Cervical Cancers
por: Qunchao Hu, et al.
Publicado: (2021)